CLSI CONCLAVE
COUNTDOWN TO THE CONCLAVE
ABOUT THE CONFERENCE
The CLSI Conclave 2026 convenes laboratory medicine professionals and healthcare leaders from the UAE and the wider Middle East to explore quality, safety, innovation and the translation of diagnostic evidence into clinical action.
Specimen integrity, patient identification, collection and handling workflows.
CLSI PRE01 · PRE02 · PRE04Monoclonal proteins, emerging biomarkers and clinical readiness for precision medicine.
CLSI EP17 · EP29AI, digital pathology, autoverification and future-ready IVD workflows.
CLSI AUTO10 · AUTO16POCT implementation, immunoassay interference and critical clinical results.
CLSI POCT 04/07 · EP07 · GP47A MESSAGE OF WELCOME
On behalf of Prime Healthcare Group and in association with the Clinical and Laboratory Standards Institute (CLSI, USA), it is our distinct honor and privilege to welcome you to the 3rd Edition of the CLSI Conclave 2026.
This year’s theme reflects a pivotal shift in modern healthcare — from diagnostic testing to precision medicine, personalized therapies and better patient outcomes.
Distinguished guests, esteemed speakers, colleagues, and leaders in laboratory medicine,
On behalf of Prime Healthcare Group and in association with the Clinical and Laboratory Standards Institute (CLSI, USA), it is my distinct honor and privilege to welcome you all to the 3rd Edition of the CLSI Conclave 2026.
This year’s theme, “The Evolving Patient Care: From Diagnostic Testing to Precision Medicine,” reflects a pivotal shift in modern healthcare. As diagnostic science advances rapidly, laboratory medicine is no longer confined to reporting numbers—it is actively shaping clinical decisions, driving personalized therapies, and improving patient outcomes.
Today, we bring together over 180 key decision-makers, pathologists, clinical biochemists, and healthcare leaders from across the UAE and the wider Middle East region. Through robust discussions, expert insights, and practical frameworks grounded in CLSI guidelines, our goal is to bridge the gap between rigorous laboratory standards and advanced clinical application.
Our agenda for the day spans critical operational and scientific frontiers:
Pre-Analytical Excellence & Error Prevention: Addressing specimen integrity, patient identification, and handling workflows (CLSI PRE01, PRE02, PRE04).
Advanced Diagnostics & Biomarkers: Evaluating monoclonal proteins (EP17), clinical readiness of brain injury markers (EP29), and blood-based biomarkers in Alzheimer's disease.
Clinical Decision-Making & Risk Management: Transforming data into actionable clinical decisions and managing critical results (GP47).
Digital Transformation, AI & Automation: Unlocking autoverification and next-generation IVD instrument workflows (AUTO10, AUTO16).
Point-of-Care & Analytical Quality: Standardizing POCT programs (POCT 04/07) and navigating immunoassay interference (I/LA30-A, EP07).
Holistic Well-being: Concluding with an interactive workshop on Mindfulness in Laboratory Medicine.
We extend our sincere gratitude to our esteemed international and regional faculty, representative dignitaries from the Dubai Health Authority (DHA), the Chamber of Commerce, CLSI, and our industry partners—especially Abbott—for their unwavering support in making this platform possible.
Thank you for joining us today. We hope this conclave inspires rich dialogue, meaningful collaboration, and actionable insights that elevate laboratory practices across our institutions.
WHO SHOULD ATTEND
Bringing together over 180 key decision-makers, pathologists, clinical biochemists and healthcare leaders.
THE FACULTY
Meet the international and regional faculty joining the 3rd Edition of the CLSI Conclave.
Chief Medical Director, Neuberg Anand Reference Laboratory, Neuberg Diagnostics Pvt Ltd, India
PhD, Consultant Clinical Biochemistry, King Fahd Armed Forces Hospital (KFAFH), MODHS, Jeddah, KSA
CEO, Diagnostics & National Reference Laboratory-M42, UAE
Clinical Pathologist & Head of department, Burjeel medical City, Abu Dhabi, UAE
Consultant Clinical Pathologist and Laboratory Director, Zulekha Hospital, UAE
Ph.D, Division Operations Manager-Clinical Chemistry, Immunology and POCT, Dubai Health, UAE
Specialist Pathologist, Prime Healthcare Group, UAE
Director of Diagnostic Services and Specialist Pathologist, Prime Healthcare Group, Dubai, UAE
SCIENTIFIC & ORGANIZING COMMITTEES
Dr. Adel Mohamed Yasin Alsisi
Chief Medical Officer & Consultant Intensive Care Unit, Prime Hospital, Dubai, UAE
Dr. Antony Thomas
Director Diagnostic Services and Specialist Pathologist, Prime Healthcare Group, Dubai, UAE
Dr. Kavita Krishnan
Head – Laboratory Services & Specialist Pathologist, Prime Healthcare Group, Dubai, UAE
Dr. Parampreet Kaur
Specialist Pathologist, Prime Healthcare Group, UAE
PROGRAM CHAIRMAN
Dr. Antony Thomas
Director Diagnostic Services and Specialist Pathologist, Prime Healthcare Group, Dubai, UAE
ORGANIZING SECRETARIES
Lolith Lohidhakshan · Tamer Said Ibrahim
MEMBERS
Sreejith Sasi · Ruthiran Ulaganathan
16 sessions
All participants
Prime Healthcare Group, CLSI, DHA representatives, Chamber of Commerce
Dr. Antony Thomas
CLSI PRE02 — Collection of Diagnostic Venous Blood Specimens; CLSI PRE01 — Patient and Laboratory Specimen Identification Processes; and CLSI PRE04 — Handling, Transport, Processing, and Storage of Blood Specimens.
Dr. Sujay Ramaprasad
An Integrated Laboratory Approach: CLSI EP17 — Evaluation of Detection Capability for Analytical Sensitivity and Detection of Monoclonal Proteins.
Dr. Amani Mohammed Taib Gusti
CLSI EP29 framework for developing new biomarkers.
Scheduled break in the scientific program.
Dr. Laila AbdelWareth
Dr. Rakesh Kumar Shah
CLSI GP47: Management of Critical- and Significant-Risk Results.
Dr. Sujay Ramaprasad
Focus on Process Workflow: CLSI AUTO10 — Autoverification of Clinical Laboratory Test Results & CLSI AUTO16-Ed2 — Next-Generation In Vitro Diagnostic Instruments.
Scheduled break in the scientific program.
Dr. Mariam Adel Labib Younan
CLSI POCT 04/07
Dr. Parampreet Kaur
Scheduled break in the scientific program.
Dr. Shiefa Sequeira
CLSI I/LA30-A and CLSI EP07-ED3
Dr. Sujay Ramaprasad with Prime & Abbott team
Prime Healthcare Group, Abbott, CLSI
No sessions found. Try another topic or speaker.
OUR PARTNERS
Prime Healthcare Group, in association with CLSI, USA, and with the support of industry partner Abbott.
VENUE
Join the CLSI Conclave at Marriott Hotel Al Jaddaf in Dubai for a day of science, discussion and collaboration.
JOIN THE CONVERSATION
Contact the event team for registration and further information.
LET’S CONNECT
For further inquiries or any clarifications,
please contact Mr. Sahan.